Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2024-07-15 13:44
Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1 2024-07-15 12:17
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases 2024-07-12 16:53
First Patient Dosed in Phase I Clinical Trial of YOLT-201 2024-07-11 20:11
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-07-11 20:00
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) 2024-07-11 14:24
ADM Korea Announces Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target as 'Prostate Cancer Patients Resistant to Hormone Therapy' 2024-07-11 14:07
Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals 2024-07-11 08:21
Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut 2024-07-10 23:00
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year 2024-07-10 13:30
Porton J-STAR and Enabling Technologies Consortium Collaboration on Co-processing Platform Technology Development 2024-07-08 22:00
Cambrex to Expand Stability Storage Business with New Facility in Durham, North Carolina 2024-07-08 18:00
DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease 2024-07-08 17:23
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME 2024-07-08 17:00
Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors 2024-07-08 16:28
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics 2024-07-08 14:30
BioCity announces its endothelin receptor A selective antagonist SC0062 met the primary endpoint in IgA nephropathy in 2-SUCCEED trial: a randomized, double-blind, placebo-controlled Phase 2 trial 2024-07-08 13:41
Olverembatinib Approved for Commercialization in Macau China 2024-07-08 08:55
Innovent Launches Environmental, Social and Governance (ESG) Website to Advance Sustainability and Corporate Responsibility 2024-07-08 08:00
FAIR PLAY MENARINI INTERNATIONAL AWARD, A MAGICAL NIGHT AT FIESOLE FOR THE GRAND FINALE 2024-07-05 21:48
1 24 25 26 27 28 412